Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Multisite Implementation of COMPRENDO

University of California, San Diego · with Dana-Farber Cancer Institute, University of California, San Francisco · NCT06055296

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
450
US sites recruiting
4
Study start
January 11, 2024
Record last updated
June 3, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting implementation. This study will test the impact of COMPRENDO, a peer-navigation intervention, vs. usual care on accrual to childhood cancer therapeutic clinical trials and parental informed consent outcomes. COMPRENDO will be delivered by trained peer navigators in 4 visits. A mixed methods (surveys, individual interviews) implementation evaluation will examine implementation factors that can inform the use of peer navigation in clinical practice, integrating data from clinicians, navigators, administrators, and parents pre and post the RCT.

Being studied: COMPRENDO Peer Navigation Intervention

Conditions: Pediatric Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Non-Stakeholder/Stakeholder Parent Eligibility criteria: A parent/legal guardian who has a Hispanic child aged 0 to 17y with a new diagnosis of cancer, has a child who is eligible for a therapeutic cancer clinical trial, will participate in an informed consent discussion for the therapeutic clinical trial, understands written and spoken English or Spanish, and has signed the consent form for the proposed COMPRENDO study. Participants will not be eligible if their child has second malignancy/relapse, was diagnosed at an outside institution, has potential transfer of care, was previously on a clinical trial

Stakeholder Clinician/Navigator/Administrator Clinicians, navigators and administrators who work at each site, are involved in treating pediatric patients and who are involved in the informed consent conference for clinical trials.

Recruiting US locations

  • Children's of Alabama/University of Alabama at Birmingham

    Birmingham, AL 35243

    Site contact: Julie A Wolfson, MD, MSHS · 205-638-9285 · jwolfson@uabmc.edu

  • Rady Children's Hospital San Diego/University of California San Diego Moores Cancer Center

    San Diego, CA 92123

    Site contact: M.Paula Aristizabal, MD, MAS · 858-966-5811 · paristizabal@rchsd.org

  • University of California San Francisco Benioff Children's Hospitals

    San Francisco, CA 94609

    Site contact: Lena Winestone, MD, MHSP · 415-476-2188 · COMPRENDO@ucsf.edu

  • Dana Farber Cancer Institute/Boston Children's Hospital

    Boston, MA 02115

    Site contact: Kira Bona, MD, MPH · 617-632-4688 · kira.bona@childrens.harvard.edu

Study contacts (from the official record)

  • M.Paula Aristizabal, MD, MAS · 858-966-5811 · paristizabal@rchsd.org
All healthy volunteers studies in Alabama →
Multisite Implementation of COMPRENDO (NCT06055296) | Bored Studies